Rubella Virus Wistar Ra 27/3 Strain (Live, Attenuated) Produced In Wi-38 Human Diploid Lung Fibroblasts, Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells, Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells

4 trials JAnti-infectives

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

2 Completed trials

4 Sponsors

3 Countries

Phase II

Phase IV

Phase II: 2 Phase IV: 2

Indications tested

Sponsors using this IMP

Gentofte Hospital 1 Rigshospitalet 1 Rijksinstituut voor Volksgezondheid en Milieu (RIVM) 1 Universite Libre de Bruxelles 1

All trials

4 total

EarLy extra Measles immunisation during a measles Outbreak (ELMO) Pending

2024-513395-18-00 Phase IV 1 country Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Enhancing infant mucosal immunity through vaccination during lactation. Pending

2025-524862-12-00 Phase IV 1 country Universite Libre de Bruxelles
Is dermal measles-mumps-rubella-vaccine administration better than regular injection? Ended

2023-503845-79-01 Phase II 1 country Rigshospitalet
Using live vaccines to induce beneficial innate immune training and reduce systemic inflammation in COPD patients Ended

2023-504519-34-01 Phase II 1 country Gentofte Hospital

Showing 1–4 of 4 trials

← All drugs A–Z